No increased extracellular volume fraction or conduction time after childhood septal myectomy

Julia Schleihauf1, Julie Cleuziou2, Christian Meierhofer1

  • 1Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany.

Insights

Surgical septal myectomy in childhood for hypertrophic cardiomyopathy does not increase myocardial fibrosis or conduction problems. This procedure is safe for managing left ventricular outflow tract obstruction long-term.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiovascular Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
  • Severe HCM in children can cause left ventricular outflow tract obstruction (LVOTO).
  • Surgical septal myectomy is a treatment option for drug-refractory LVOTO in pediatric HCM.

Purpose of the Study:

  • To evaluate the long-term effects of early childhood septal myectomy on myocardial extracellular volume fraction.
  • To assess the risk of atrioventricular conduction system disease after pediatric septal myectomy.
  • To investigate the impact of septal myectomy on myocardial fibrosis in pediatric HCM.

Main Methods:

  • Retrospective review of 30 pediatric HCM patients.
  • Cardiovascular magnetic resonance (CMR) with T1 mapping and late gadolinium enhancement.
  • Comparison between 12 myectomy patients and 18 non-operated patients.

Main Results:

  • Septal myocardial fibrosis (late gadolinium enhancement) was present in 53% of patients, with no group difference.
  • Extracellular volume fraction, a marker of diffuse fibrosis, was similar in myectomy and non-operated groups.
  • No significant difference in PQ-intervals or higher-degree atrioventricular conduction disease between groups.

Conclusions:

  • Pediatric septal myectomy does not increase septal extracellular volume fraction.
  • The procedure does not lead to delayed atrioventricular conduction times on long-term follow-up.
  • Septal myectomy is a safe intervention for severe obstructive HCM in early childhood.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
333
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
310
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
167
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
194
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
224
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
607